LOINC
Version 2.67

61044-4LORazepam [Presence] in Unspecified specimenActive

Part Descriptions

LP16176-7   LORazepam
Lorazepam (marketed under the brand names Ativan®, Temesta®, Tavor®) is a drug which is a benzodiazepine derivative. Pharmacologically, it is classified as a sedative -hypnotic, anxiolytic and anticonvulsant. Lorazepam reduces anxiety, interferes with new memory formation, reduces agitation, induces sleep, treats seizures, treats nausea and vomiting, and relaxes muscles. Lorazepam is used for the short-term treatment of anxiety, insomnia, acute seizures including status epilepticus, and sedation of hospitalized patients, as well as sedation of aggressive patients. Due to tolerance and dependence, lorazepam is recommended for short-term use, up to two to four weeks only. Among benzodiazepines, lorazepam has possible physical addiction potential. Lorazepam also has misuse potential; the main types of misuse are for recreational purposes. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Lorazepam (Wikipedia)

LP16176-7   LORazepam
A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Source: National Library of Medicine, MeSH 2006

Fully-Specified Name

Component
LORazepam
Property
PrThr
Time
Pt
System
XXX
Scale
Ord
Method

Additional Names

Short Name
LORazepam XXX Ql
Display Name
LORazepam Ql (Unsp spec)

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.34
Last Updated
Version 2.56
Change Reason
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Example Answer List LL360-9

Source: Regenstrief Institute

Answer Code Score Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6

Member of these Groups

LG37571-3 Lorazepam|ANYProp|ANYTm|ANYSys|ANYMeth

Language Variants Get Info

zh-CNChinese (CHINA)
氯羟安定:存在情况或阈值:时间点:XXX:序数型:
nl-NLDutch (NETHERLANDS)
lorazepam:aanwezigheid:moment:XXX:ordinaal:
et-EEEstonian (ESTONIA)
Lorasepaam:PrThr:Pt:XXX:Ord:
fr-BEFrench (BELGIUM)
Lorazépam:PrThr:Temps ponctuel:XXX:Ordinal:
fr-CAFrench (CANADA)
Lorazépam:Présence-Seuil:Temps ponctuel:XXX:Ordinal:
fr-FRFrench (FRANCE)
Lorazépam:Présence/Seuil:Ponctuel:Milieux divers:Qualitatif:
it-ITItalian (ITALY)
Lorazepam:PrThr:Pt:XXX:Ord:
pt-BRPortuguese (BRAZIL)
ru-RURussian (RUSSIAN FEDERATION)
Лоразепам:PrThr:ТчкВрм:XXX:Пор:
es-ESSpanish (SPAIN)
Lorazepam:PrThr:Punto temporal:XXX:Ord:
tr-TRTurkish (TURKEY)
Lorazepam:MevcEşik:Zmlı:XXX:Srl:

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=61044-4